Endometriosis: Difference between revisions

 
Line 1: Line 1:
==Background==
==Background==
[[File:Figure 28 02 01.png|thumb|Normal female anatomy with uterus highlighted.]]
[[File:Uterine arterial vasculature.svg|thumb|Diagram of uterine blood supply.]]
*Endometrial glands and stroma at extrauterine sites, generally in the pelvis but can be anywhere in the body
*Endometrial glands and stroma at extrauterine sites, generally in the pelvis but can be anywhere in the body
*The condition is a common, benign, estrogen-dependent disorder
*The condition is a common, benign, estrogen-dependent disorder

Latest revision as of 16:49, 1 May 2024

Background

Normal female anatomy with uterus highlighted.
Diagram of uterine blood supply.
  • Endometrial glands and stroma at extrauterine sites, generally in the pelvis but can be anywhere in the body
  • The condition is a common, benign, estrogen-dependent disorder
  • Can be associated with debilitating symptoms

Clinical Features

  • Classic symptoms: dysmenorrhea, pelvic pain, dyspareunia, and infertility
  • Mnemonic: 3 D's--dysmenorrhea, dyschezia and dyspareunia
  • Other symptoms may include: include abnormal uterine bleeding, low back pain, or chronic fatigue
  • Endometriosis is commonly detected as an asymptomatic incidental finding on pelvic ultrasound or during a surgical procedure
  • Catamenial pneumothorax- rare complication involving recurrent spontaneous pneumothoraces occurring around menses

Differential Diagnosis

Acute Pelvic Pain

Differential diagnosis of acute pelvic pain

Gynecologic/Obstetric

Genitourinary

Gastrointestinal

Musculoskeletal

Vascular

Nonpregnant Vaginal Bleeding

Systemic Causes

Reproductive Tract Causes

Evaluation

  • History of symptoms described above
  • Exam with tenderness when palpating posterior fornix
  • Labs are not generally useful
  • Pelvic ultrasound is the first-line study
  • Laparoscopy for definitive diagnosis

Management

  • Symptomatic management
  • Analgesia
  • Hormonal medical therapy
    • OCP's, GnRH agonists, progestins, danazol, aromatase inhibitors
  • Surgical intervention - conservative (retain uterus and ovaries) or definitive (TAH-BSO)

Disposition

  • Discharge with OB/Gyn follow-up

See Also

External Links

References

  1. Norris DL, Young JD. UTI. EM Clin N Am. 2008; 26:413-30.